LGC Ltd. of Teddington at MEDICA 2022 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Company news

Date

Topic

21 Sep 2022

TRC supports research on neurodegenerative diseases and mental disorders

Advances in immunology, genomics and AI are helping to shine a light on the complexity of the human brain as never before, but significant gaps in our understanding are holding back therapeutic development in areas such as Alzheimer’s, Parkinson’s, Huntington’s disease, multiple sclerosis, schizophrenia, stress and anxiety,
addiction and depression.

TRC provides a uniquely large range of research neurochemicals, including bioactive molecules, APIs, impurities and metabolites, controlled substances and more than 21,000 stable isotope labelled standards to explore:

- Neurotransmission
- Dopamine receptors
- 5-HT receptors
- Adrenergic receptors
- GABA receptors
- Opioid receptors
- Cannabinoid receptors
- Acetylcholine receptors
- Calcium channels
- Estrogen receptors

We specialize in solving complex chemical synthesis problems, with our expert chemists ready to discuss your synthesis challenges.

Contact us at: +1 (416) 665-9696
US & Canada: +1 (800) 727-9240
Email: info.trc@lgcgroup.com

TRC. Products for Innovative Research

More Less

Please log in

You must be logged in to use matchmaking